306 related articles for article (PubMed ID: 12492488)
1. Kininogen-derived peptides for investigating the putative vasoactive properties of human cathepsins K and L.
Desmazes C; Galineau L; Gauthier F; Brömme D; Lalmanach G
Eur J Biochem; 2003 Jan; 270(1):171-8. PubMed ID: 12492488
[TBL] [Abstract][Full Text] [Related]
2. Cathepsin K: a cysteine protease with unique kinin-degrading properties.
Godat E; Lecaille F; Desmazes C; Duchêne S; Weidauer E; Saftig P; Brömme D; Vandier C; Lalmanach G
Biochem J; 2004 Nov; 383(Pt. 3):501-6. PubMed ID: 15265002
[TBL] [Abstract][Full Text] [Related]
3. Cathepsin L, but not cathepsin B, is a potential kininogenase.
Desmazes C; Gauthier F; Lalmanach G
Biol Chem; 2001 May; 382(5):811-5. PubMed ID: 11517935
[TBL] [Abstract][Full Text] [Related]
4. Kininogen-derived fluorogenic substrates for investigating the vasoactive properties of rat tissue kallikreins--identification of a T-kinin-releasing rat kallikrein.
El Moujahed A; Brillard-Bourdet M; Juliano MA; Moreau T; Chagas JR; Gutman N; Prado ES; Gauthier F
Eur J Biochem; 1997 Jul; 247(2):652-8. PubMed ID: 9266709
[TBL] [Abstract][Full Text] [Related]
5. The carboxyl terminus of bradykinin and amino terminus of the light chain of kininogens comprise an endothelial cell binding domain.
Hasan AA; Cines DB; Zhang J; Schmaier AH
J Biol Chem; 1994 Dec; 269(50):31822-30. PubMed ID: 7989355
[TBL] [Abstract][Full Text] [Related]
6. S(1)' and S(2)' subsite specificities of human plasma kallikrein and tissue kallikrein 1 for the hydrolysis of peptides derived from the bradykinin domain of human kininogen.
Lima AR; Alves FM; Angelo PF; Andrade D; Blaber SI; Blaber M; Juliano L; Juliano MA
Biol Chem; 2008 Dec; 389(12):1487-94. PubMed ID: 18844446
[TBL] [Abstract][Full Text] [Related]
7. Differences in substrate and inhibitor sequence specificity of human, mouse and rat tissue kallikreins.
Fogaça SE; Melo RL; Pimenta DC; Hosoi K; Juliano L; Juliano MA
Biochem J; 2004 Jun; 380(Pt 3):775-81. PubMed ID: 15040788
[TBL] [Abstract][Full Text] [Related]
8. A possible alternative mechanism of kinin generation in vivo by cathepsin L.
Puzer L; Vercesi J; Alves MF; Barros NM; Araujo MS; Aparecida Juliano M; Reis ML; Juliano L; Carmona AK
Biol Chem; 2005 Jul; 386(7):699-704. PubMed ID: 16207091
[TBL] [Abstract][Full Text] [Related]
9. Comparative substrate specificity analysis of recombinant human cathepsin V and cathepsin L.
Puzer L; Cotrin SS; Alves MF; Egborge T; Araújo MS; Juliano MA; Juliano L; Brömme D; Carmona AK
Arch Biochem Biophys; 2004 Oct; 430(2):274-83. PubMed ID: 15369827
[TBL] [Abstract][Full Text] [Related]
10. Release of biologically active kinin peptides, Met-Lys-bradykinin and Leu-Met-Lys-bradykinin from human kininogens by two major secreted aspartic proteases of Candida parapsilosis.
Bras G; Bochenska O; Rapala-Kozik M; Guevara-Lora I; Faussner A; Kamysz W; Kozik A
Peptides; 2013 Oct; 48():114-23. PubMed ID: 23954712
[TBL] [Abstract][Full Text] [Related]
11. Generation of vasoactive peptide bradykinin from human umbilical vein endothelium-bound high molecular weight kininogen by plasma kallikrein.
Nishikawa K; Shibayama Y; Kuna P; Calcaterra E; Kaplan AP; Reddigari SR
Blood; 1992 Oct; 80(8):1980-8. PubMed ID: 1391955
[TBL] [Abstract][Full Text] [Related]
12. Human bradykinin B(2) receptor is activated by kallikrein and other serine proteases.
Hecquet C; Tan F; Marcic BM; Erdös EG
Mol Pharmacol; 2000 Oct; 58(4):828-36. PubMed ID: 10999954
[TBL] [Abstract][Full Text] [Related]
13. Attenuated kinin release from human neutrophil elastase-pretreated kininogens by tissue and plasma kallikreins.
Dulinski R; Suder P; Guevara-Lora I; Rapała-Kozik M; Potempa J; Silberring J; Imamura T; Travis J; Kozik A
Biol Chem; 2003 Jun; 384(6):929-37. PubMed ID: 12887060
[TBL] [Abstract][Full Text] [Related]
14. Distinct properties of prohormone thiol protease (PTP) compared to cathepsins B, L, and H: evidence for PTP as a novel cysteine protease.
Azaryan AV; Hook VY
Arch Biochem Biophys; 1994 Oct; 314(1):171-7. PubMed ID: 7944391
[TBL] [Abstract][Full Text] [Related]
15. Limited proteolysis of T-kininogen (thiostatin). Release of comparable fragments by different endopeptidases.
Moreau T; Gutman N; Faucher D; Gauthier F
J Biol Chem; 1989 Mar; 264(8):4298-303. PubMed ID: 2647733
[TBL] [Abstract][Full Text] [Related]
16. Mechanism of enhanced kinin release from high molecular weight kininogen by plasma kallikrein after its exposure to plasmin.
Kleniewski J; Blankenship DT; Cardin AD; Donaldson V
J Lab Clin Med; 1992 Jul; 120(1):129-39. PubMed ID: 1535355
[TBL] [Abstract][Full Text] [Related]
17. Kinin generation from exogenous kininogens at the surface of retinoic acid-differentiated human neuroblastoma IMR-32 cells after stimulation with interferon-γ.
Guevara-Lora I; Majkucinska M; Barbasz A; Faussner A; Kozik A
Peptides; 2011 Jun; 32(6):1193-200. PubMed ID: 21549779
[TBL] [Abstract][Full Text] [Related]
18. Substrate specificity of recombinant cysteine proteinase, CPB, of Leishmania mexicana.
Alves LC; Judice WA; St Hilaire PM; Meldal M; Sanderson SJ; Mottram JC; Coombs GH; Juliano L; Juliano MA
Mol Biochem Parasitol; 2001 Aug; 116(1):1-9. PubMed ID: 11463460
[TBL] [Abstract][Full Text] [Related]
19. Release of endothelial-derived kallikrein, kininogen and kinins.
Nolly H; Nolly A
Biol Res; 1998; 31(3):169-74. PubMed ID: 9830504
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of the extent of the binding site in human tissue kallikrein by synthetic substrates with sequences of human kininogen fragments.
Del Nery E; Chagas JR; Juliano MA; Prado ES; Juliano L
Biochem J; 1995 Nov; 312 ( Pt 1)(Pt 1):233-8. PubMed ID: 7492318
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
